Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IASO Bio Announces U.S. FDA Approval of Clinical Trial Application for BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma 2022-12-22 16:38
Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease 2022-12-21 22:00
Waterdrop Chief Actuary Hui Teng: Good Products and Services Are the Underlying Logic of High-quality Transformation for Health Insurance 2022-12-21 21:30
I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with "Special Recognition in Cell Therapy" 2022-12-21 15:10
QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings 2022-12-21 10:30
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index 2022-12-21 08:00
PENTAX Medical U.S. launches endoscope drying solution PlasmaTYPHOONdry 2022-12-21 06:16
Edan Medical UK Pointed out the Trend of Healthcare Innovation on the Interview Broadcasted on Sky TV 2022-12-20 22:34
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries 2022-12-20 17:00
Korea Ginseng Corp. enhances its reputation as a leading herbal dietary brand by revealing a new set of stocking stuffers 2022-12-20 15:23
Shen Peng Awarded Charitable Entrepreneur of For Good Awards 2022 2022-12-19 22:00
SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit 2022-12-19 21:00
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON 2022-12-19 21:00
GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab) 2022-12-19 19:00
TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody 2022-12-17 21:30
Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States 2022-12-16 16:04
Zhejiang Doer Biologics Announces Clinical Trial Collaboration with MSD to Evaluate DR30303 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Gastric or Gastroesophageal Junction Cancer 2022-12-16 09:00
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List 2022-12-16 08:44
Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE 2022-12-16 08:42
1 88 89 90 91 92 766